These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 6376719)
41. [Neoadjuvant chemotherapy for elderly advanced gastric cancer: a case report of MTX/5-FU sequential therapy followed by radical gastrectomy]. Saitoh A; Fukuhara T; Kikuchi H; Tsushima K; Tanaka M; Kudoh H; Narita N; Sakata Y Gan To Kagaku Ryoho; 1994 Sep; 21(12):2039-43. PubMed ID: 8085855 [TBL] [Abstract][Full Text] [Related]
42. Neoadjuvant and adjuvant methotrexate, cisplatin, and fluorouracil in multimodal therapy of head and neck cancer. Vokes EE; Moran WJ; Mick R; Weichselbaum RR; Panje WR J Clin Oncol; 1989 Jul; 7(7):838-45. PubMed ID: 2661732 [TBL] [Abstract][Full Text] [Related]
43. Adjuvant chemotherapy for high-risk squamous-cell carcinoma of the head and neck. Johnson JT; Myers EN; Schramm VL; Mayernik DG; Nolan TA; Sigler BA; Wagner RL J Clin Oncol; 1987 Mar; 5(3):456-8. PubMed ID: 3546619 [TBL] [Abstract][Full Text] [Related]
44. [Randomized multicenter trial of sequential methotrexate and 5-fluorouracil versus 5-fluorouracil alone in advanced gastric cancer]. Sasaki T; Ota K; Ibayashi J; Sakata Y; Matsuoka T; Ishikawa M; Wakui A; Ogoshi K; Akazawa S; Sakai Y Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2545-55. PubMed ID: 2673045 [TBL] [Abstract][Full Text] [Related]
45. Methotrexate and 5-fluorouracil in head and neck cancer. Ringborg U; Ewert G; Kinnman J; Lundquist PG; Strander H Semin Oncol; 1983 Jun; 10(2 Suppl 2):20-2. PubMed ID: 6603022 [TBL] [Abstract][Full Text] [Related]
46. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma. Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506 [TBL] [Abstract][Full Text] [Related]
47. Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group. Valone FH; Friedman MA; Wittlinger PS; Drakes T; Eisenberg PD; Malec M; Hannigan JF; Brown BW J Clin Oncol; 1989 Oct; 7(10):1427-36. PubMed ID: 2789272 [TBL] [Abstract][Full Text] [Related]
48. Survival results from a phase III study of simultaneous versus 1-hour sequential methotrexate-5-fluorouracil chemotherapy in head and neck cancer. Browman GP; Levine MN; Russell R; Young JE; Archibald SD Head Neck Surg; 1986; 8(3):146-52. PubMed ID: 3528055 [TBL] [Abstract][Full Text] [Related]
49. A prospective randomized trial of fluorouracil versus fluorouracil plus cisplatin in the treatment of metastatic colorectal cancer: a Hoosier Oncology Group trial. Loehrer PJ; Turner S; Kubilis P; Hui S; Correa J; Ansari R; Stephens D; Woodburn R; Meyer S J Clin Oncol; 1988 Apr; 6(4):642-8. PubMed ID: 3282033 [TBL] [Abstract][Full Text] [Related]
50. Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma. Poon MA; O'Connell MJ; Moertel CG; Wieand HS; Cullinan SA; Everson LK; Krook JE; Mailliard JA; Laurie JA; Tschetter LK J Clin Oncol; 1989 Oct; 7(10):1407-18. PubMed ID: 2476530 [TBL] [Abstract][Full Text] [Related]
51. Sequential methotrexate, 5-fluorouracil, and calcium leucovorin in colorectal carcinoma. Hansen RM; Ritch PS; Anderson T Am J Clin Oncol; 1986 Aug; 9(4):352-4. PubMed ID: 3489407 [TBL] [Abstract][Full Text] [Related]
52. Sequential chemotherapy of advanced colorectal cancer with standard or high-dose methotrexate followed by 5-fluorouracil. Solan A; Vogl SE; Kaplan BH; Berenzweig M; Richard J; Lanham R Med Pediatr Oncol; 1982; 10(2):145-9. PubMed ID: 7040929 [TBL] [Abstract][Full Text] [Related]
53. [Sequential methotrexate/5-fluorouracil therapy with 5'-deoxy-5-fluorouridine against advanced gastric cancer: comparison between bolus injection and drip infusion of 5-fluorouracil administration. Hirosaki Cooperative Study Group for Cancer Chemotherapy]. Yamada Y; Tsushima K; Sakata Y; Saito S; Ito T; Sugimoto N; Ogasawara H; Tamura Y; Moriya N; Komatsu Y Gan To Kagaku Ryoho; 1994 Jun; 21(7):1029-32. PubMed ID: 8210253 [TBL] [Abstract][Full Text] [Related]
54. Modulation of high-dose infusional fluorouracil by low-dose methotrexate in patients with advanced or metastatic colorectal cancer: final results of a randomized European Organization for Research and Treatment of Cancer Study. Blijham G; Wagener T; Wils J; de Greve J; Buset M; Bleiberg H; Lacave A; Dalmark M; Selleslag J; Collette L; Sahmoud T J Clin Oncol; 1996 Aug; 14(8):2266-73. PubMed ID: 8708716 [TBL] [Abstract][Full Text] [Related]
55. Prospective randomized trial of high-dose cisplatin and fluorouracil infusion with or without sodium diethyldithiocarbamate in recurrent and/or metastatic squamous cell carcinoma of the head and neck. Paredes J; Hong WK; Felder TB; Dimery IW; Choksi AJ; Newman RA; Castellanos AM; Robbins KT; McCarthy K; Atkinson N J Clin Oncol; 1988 Jun; 6(6):955-62. PubMed ID: 2836565 [TBL] [Abstract][Full Text] [Related]
56. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer. Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775 [TBL] [Abstract][Full Text] [Related]
57. [Improving the anti-tumor activity of 5-fluorouracil by methotrexate]. Konishi T; Noie T; Abe T; Agawa S; Furushima K; Ito K; Mafune K; Makuuchi M; Teruya M; Nouchi T Gan To Kagaku Ryoho; 1999 Mar; 26(4):431-9. PubMed ID: 10097739 [TBL] [Abstract][Full Text] [Related]
58. [Intra-aortic infusion therapy with sequential methotrexate (MTX) and 5-FU in advanced gastric carcinoma]. Kitamura M; Awane Y; Konishi T; Suzuki T; Arai K; Kosaki G; Sasaki T Gan To Kagaku Ryoho; 1986 May; 13(5):1927-33. PubMed ID: 3486635 [TBL] [Abstract][Full Text] [Related]
59. Combination chemotherapy (5-fluorouracil, methyl-CCNU, mitomycin C) versus 5-fluorouracil alone for advanced previously untreated colorectal carcinoma. A phase III study of the Piedmont Oncology Association. Richards F; Case LD; White DR; Muss HB; Spurr CL; Jackson DV; Cooper MR; Zekan P; Cruz J; Stuart JJ J Clin Oncol; 1986 Apr; 4(4):565-70. PubMed ID: 3514806 [TBL] [Abstract][Full Text] [Related]
60. 5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group. Colucci G; Maiello E; Gebbia V; Giuliani F; Serravezza G; Lelli G; Leo S; Filippelli G; Nicolella G; Brandi M Cancer; 1999 Feb; 85(3):535-45. PubMed ID: 10091727 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]